The CEO of Novo Nordisk Pharmatech has been a part of the Novo Nordisk group since 1997 and the CEO of Pharmatech since 2021.
“Leaving is not an easy decision. Novo Nordisk has been part of my professional life and part of my DNA for more than 29 years. It has shaped me as a leader and as a person, and it will always be part of who I am. It has been a true privilege to work alongside so many talented, dedicated, and courageous colleagues,” Krogsgaard Thomsen says in a press release.